TCMD

Healthcare

Tactile Systems Technology, Inc.

Fundamentals7.0

Price Action4.0

News Sentiment0.0

AI Rating

6.0

Key Drivers

Strong Liquidity
Low Leverage
Cash Flow

AI
AI Summary

6.0

TCMD is now an execution-and-reacceleration investment: its strong balance sheet limits downside from financial distress, but investors should wait for revenue delivery within $360–$366M guidance, stable margins, and improved free-cash-flow conversion before underwriting a rerating or assigning value to the unproven battery-powered device.

LiquidityStrength

ExecutionRisk

RevenueGuidance‍

Price Chart

Loading chart...

Financial Metrics

Revenue (TTM)

Net Income (TTM)

EPS (Q)

MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

•Strong Liquidity
•Low Leverage
•Cash Flow

TCMD has strong liquidity, low leverage, and solid profitability, but its elevated valuation and softer quarterly cash flow warrant disciplined entry timing.

FinancialStrength

ValuationRisk

Price Behavior

4.0

Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

•Lower highs
•Failed rebound
•Weak momentum

TCMD remains bearish over the last month, with a failed rebound and weak momentum; watch $21.73 support, while a sustained break above $22.60 would improve the outlook.

bearish

watchlist

Support Level: $21.73

Resistance Level: $22.50–$22.60

Brief rebound from $21.73 to $22.57 failed to hold